Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a d...
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
FY 2024
Dec 31, 2024
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024